Correlation Between Neuropace and Artivion
Can any of the company-specific risk be diversified away by investing in both Neuropace and Artivion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Artivion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Artivion, you can compare the effects of market volatilities on Neuropace and Artivion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Artivion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Artivion.
Diversification Opportunities for Neuropace and Artivion
Very weak diversification
The 3 months correlation between Neuropace and Artivion is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Artivion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artivion and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Artivion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artivion has no effect on the direction of Neuropace i.e., Neuropace and Artivion go up and down completely randomly.
Pair Corralation between Neuropace and Artivion
Given the investment horizon of 90 days Neuropace is expected to generate 1.86 times more return on investment than Artivion. However, Neuropace is 1.86 times more volatile than Artivion. It trades about 0.13 of its potential returns per unit of risk. Artivion is currently generating about -0.12 per unit of risk. If you would invest 1,060 in Neuropace on November 29, 2024 and sell it today you would earn a total of 288.00 from holding Neuropace or generate 27.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Neuropace vs. Artivion
Performance |
Timeline |
Neuropace |
Artivion |
Neuropace and Artivion Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and Artivion
The main advantage of trading using opposite Neuropace and Artivion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Artivion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artivion will offset losses from the drop in Artivion's long position.Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Artivion vs. Anika Therapeutics | Artivion vs. Sight Sciences | Artivion vs. Orthofix Medical | Artivion vs. Avanos Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
CEOs Directory Screen CEOs from public companies around the world |